Segments - Pharma Grade Sodium Hydroxide Market by Type (Liquid Sodium Hydroxide and Solid Sodium Hydroxide), Application (Pharmaceutical, Biotechnology, and Scientific Research), and Region (North America, Asia Pacific, Europe, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global pharma grade sodium hydroxide market size was USD 2.79 Billion in 2022 and is anticipated to reach USD 4.79 Billion by 2031, expanding at a CAGR of 6.20% during 2023-2031. Increasing usage of sodium hydroxide in the pharmaceutical industry and rising awareness regarding the benefits of sodium hydroxide in cosmetics are the factors driving the growth of the Pharma Grade Sodium Hydroxide market.
Sodium hydroxide is a white crystalline odorless substance that can moisture from the air at surrounding temperatures. It is a material that has been synthesized. It releases significant amounts of heat when dissolved in water or neutralized with acid, which could be enough to ignite inflammable objects.
Sodium hydroxide is a corrosive substance. Sodium hydroxide is typically used in cosmetics for the saponification of oils to make handmade soap. Sodium hydroxide is a pH balancer found in a variety of cosmetics and skincare products, including cleansers, soaps, makeup, and creams.
Research in pharma-grade sodium hydroxide made a significant contribution to the development of products and technologies. Research is required for advanced development in product design.
Companies in nearly every industry rely on R&D to plan, design, and deliver innovative products and thus, they are focusing on advancements in the pharma-grade sodium hydroxide market. Research and development in the field of chemical production and processing are creating a conducive environment for use.
The development of healthcare infrastructure is expected to drive the market. Growing investments in healthcare infrastructure by various countries is propelling the market. Rising standards in the healthcare industry in countries such as India, China, and Japan are expected to increase the demand for medical technology in Asia Pacific. Additionally, the US has the largest healthcare infrastructure in the world.
GDP across countries declined, due to the COVID-19 pandemic. Manufacturers are facing several challenges, due to restrictions and limitations in the supply chain, caused by lockdowns. These challenges are expected to slow down production during the pandemic.
Increasing government initiatives in the healthcare and pharmaceutical industries are estimated to fuel the market. Penetration of key players and the emergence of domestic players are expected to raise the employment scale.
Sodium hydroxide is typically used in cosmetics for the saponification of oils to make handmade soap. Sodium hydroxide is a pH balancer found in a variety of cosmetics and skincare products, including cleansers, soaps, makeup, and creams & lotions.
Sodium hydroxide is exceedingly dangerous in its pure form; however cosmetic and skin care products contain little sodium hydroxide and are therefore safe to use. Increasing usage and awareness of sodium hydroxide in the cosmetics products industry is expected to drive the market in the future.
The manufacture of sodium hydroxide is an energy-intensive process that results in high production costs. This is expected to stifle market expansion. Price fluctuations in the sodium hydroxide market are expected to continue to influence market trends over the projected period.
The Occupational Safety and Health Administration (OSHA) created rules to restrict exposure to sodium hydroxide in locations where it is manufactured or utilized. The National Institute for Occupational Safety and Health provides general safety rules for using and transporting sodium hydroxide, including packaging and storage, spillage, and disposal.
Manufacturers increased production while focusing on quality and efficiency, to meet industry-specific requirements. Manufacturers of sodium hydroxide are adopting strategies such as product launches to strengthen their product portfolio.
Key market players are entering into strategic acquisitions and collaborations to solidify their footprint in the market. INOVYN announced its intention to build a substantial expansion project at Norway's Rafnes Site. The project extension involves a 35-kilometric-ton-per-annum membrane ECU capacity of sodium hydroxide to be delivered to clients in Scandinavia.
BorsodChem's new membrane chlorine facility in Kazincbarcika, Hungary, successfully started producing chloralkali. Hence, increasing the production capacities of key market players acts as an opportunity for the market players can aid in boosting the pharma grade sodium market.
The report on the global Pharma Grade Sodium Hydroxide market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Pharma Grade Sodium Hydroxide Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2019 and 2020 |
Forecast Period |
2023–2031 |
Segmentation |
Type (Liquid Sodium Hydroxide and Solid Sodium Hydroxide) and Application (Pharmaceutical, Biotechnology, and Scientific Research) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered |
BioSpectra, Inc, Columbus Chemicals, DCW Ltd, Hunan Erkang Pharmaceutical Co., Ltd., ICL, NAMA Chemicals, Occidental Petroleum Corporation, PCC Rokita SA, TGV SRAAC LIMITED, Westlake Corporation |
Based on types, the pharma grade sodium hydroxide market is segmented into liquid sodium hydroxide and solid sodium hydroxide. The solid sodium hydroxide segment is expected to register substantial growth in the forecast period due to the increasing usage of sodium hydroxide in manufacturing a variety of medicines and pharmaceutical products.
Pharma grade sodium hydroxide is widely used for manufacturing medicines from common pain relievers like aspirin to anticoagulants that can help to prevent blood clots, to cholesterol-reducing medicines.
The liquid sodium hydroxide segment is expected to register a considerable CAGR during the forecast period as it is widely used in a wide range of applications including food additives, chemical fibers, water and sewerage, paper and pulp, and as a chemical agent. Sodium hydroxide is used as an ingredient in food preservatives that help prevent bacteria and mold from growing in food.
On the basis of application, the market is fragmented into pharmaceuticals, biotechnology, and scientific research.
The pharmaceuticals sector is anticipated to hold a major share of the global market in the coming years due to the extensive use of sodium hydroxide to manufacture medicines that are commonly used and pharmaceutical products.
It is primarily used in the production of anti-influenza medicaments as a sodium carrier. It is also used in the production of sulfonamides and salicylic acid. However, the scientific research segment is expected to register a considerable CAGR in the coming years due to the increasing usage of pharma grade sodium hydroxide for research purposes to increase the application across various industries.
On the basis of regions, the global sodium hydroxide market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
The market in North America is expected to register a considerable CAGR during the forecast period owing to the significant demand for sodium hydroxide among research institutes in the region. The presence of a well-established pharmaceutical industry with an increasing demand for sodium hydroxide for medicinal purposes can drive the global market.
The market in Asia Pacific is to register a considerable CAGR during the forecast period due to the high demand for sodium hydroxide from the pulp and paper chemicals industry in the region. Increasing demand for sodium hydroxide in the region with a wide range of applications and in terms of revenue generation.
Manufacturers operating in the global Pharma Grade Sodium Hydroxide market include BioSpectra, Inc, Columbus Chemicals, DCW Ltd, Hunan Erkang Pharmaceutical Co., Ltd., ICL, NAMA Chemicals, Occidental Petroleum Corporation, PCC Rokita SA, TGV SRAAC LIMITED, Westlake Corporation.
Market Players are pursuing key strategies such as acquisitions, collaborations, and geographic expansion where a potential opportunity arises for the Pharma Grade Sodium Hydroxide Market.
The global pharma grade sodium hydroxide market size was USD 2.79 Bn in 2022 and is anticipated to reach USD 4.79 Bn by 2031, expanding at a CAGR of 6.20% during 2023-2031.
Increasing usage of sodium hydroxide in pharmaceutical industry and rising awareness regarding the benefits of sodium hydroxide in cosmetics are the factors driving the growth of Pharma Grade Sodium Hydroxide market.
North America is likely to dominate the Pharma Grade Sodium Hydroxide market during the forecast period.
Major manufacturers include BioSpectra, Inc, Columbus Chemicals, DCW Ltd, Hunan Erkang Pharmaceutical Co., Ltd., ICL, NAMA Chemicals, Occidental Petroleum Corporation, PCC Rokita SA, TGV SRAAC LIMITED, and Westlake Corporation.